Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 25;9(7):701.
doi: 10.3390/vaccines9070701.

Psychological Determinants of COVID-19 Vaccine Acceptance among Healthcare Workers in Kuwait: A Cross-Sectional Study Using the 5C and Vaccine Conspiracy Beliefs Scales

Affiliations

Psychological Determinants of COVID-19 Vaccine Acceptance among Healthcare Workers in Kuwait: A Cross-Sectional Study Using the 5C and Vaccine Conspiracy Beliefs Scales

Mariam Al-Sanafi et al. Vaccines (Basel). .

Abstract

Acceptance of coronavirus disease 2019 (COVID-19) vaccination appears as a decisive factor necessary to control the ongoing pandemic. Healthcare workers (HCWs) are among the highest risk groups for infection. The current study aimed to evaluate COVID-19 vaccine acceptance among HCWs in Kuwait, with identification of the psychological determinants of COVID-19 vaccine hesitancy. The study was conducted using an online anonymous survey distributed between 18 March 2021 and 29 March 2021. The sampling strategy was convenience-based depending on chain-referral sampling. Psychological determinants of COVID-19 vaccine acceptance were assessed using the 5C subscales and the Vaccine Conspiracy Beliefs Scale (VCBS). The total number of study participants was 1019, with the largest group being physicians (28.7%), pharmacists (20.2%), dentists (16.7%), and nurses (12.5%). The overall rate for COVID-19 vaccine acceptance was 83.3%, with 9.0% who were not willing to accept vaccination and 7.7% who were unsure. The highest rate for COVID-19 vaccine acceptance was seen among dentists (91.2%) and physicians (90.4%), while the lowest rate was seen among nurses (70.1%; p < 0.001). A higher level of COVID-19 vaccine hesitancy was found among females, participants with a lower educational level, and HCWs in the private sector. A preference for mRNA vaccine technology and Pfizer-BioNTech COVID-19 vaccine was found among the majority of participants (62.6% and 69.7%, respectively). COVID-19 vaccine hesitancy was significantly linked to the embrace of vaccine conspiracy beliefs. The highest 5C psychological predictors of COVID-19 vaccine acceptance were high levels of collective responsibility and confidence, and lower levels of constraints and calculation. The VCBS and 5C subscales (except the calculation subscale) showed acceptable levels of predicting COVID-19 vaccine acceptance based on receiver operating characteristic analyses. The participants who depended on social media platforms, TV programs, and news releases as their main sources of knowledge about COVID-19 vaccines showed higher rates of COVID-19 vaccine hesitancy. An overall satisfactory level of COVID-19 vaccine acceptance was seen among HCWs in Kuwait, which was among the highest rates reported globally. However; higher levels of vaccine hesitancy were observed among certain groups (females, nurses and laboratory workers, HCWs in the private sector), which should be targeted with more focused awareness programs. HCWs in Kuwait can play a central role in educating their patients and the general public about the benefits of COVID-19 vaccination to halt the spread of SARS-CoV-2, considering the high rates of vaccine hesitancy observed among the general public in Kuwait and the Middle East.

Keywords: SARS-CoV-2 prevention; anti-vaccine; intention to vaccinate; vaccine hesitancy; vaccine rejection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The preference of COVID-19 vaccine class and type (developer) stratified based on intention to receive vaccination.
Figure 2
Figure 2
Change in COVID-19 vaccine preference over the survey dates (Pfizer-BioNTech vaccine vs. Oxford-AstraZeneca vaccine).
Figure 3
Figure 3
Intent to receive COVID-19 vaccination based on belief regarding virus origin and general attitude toward vaccination.
Figure 4
Figure 4
The correlation between vaccine conspiracy belief scale and intention to receive COVID-19 vaccination. p value was calculated using ANOVA test. The circles represent mild outliers.
Figure 5
Figure 5
Analysis of COVID-19 vaccine acceptance among HCWs in Kuwait stratified based on the 5C subscales and the vaccine conspiracy belief scale (VCBS). p values are calculated based on ANOVA with Bonferroni corrections. CI: confidence interval of the mean.
Figure 6
Figure 6
Multinomial regression analysis of the five psychological antecedents (subscales) for COVID-19 vaccine hesitancy and their association with COVID-19 vaccine hesitancy (intent to receive COVID-19 vaccination with no/maybe responses). The mean odds ratio is represented by the diamond blue shape, while the 95% confidence interval is displayed as the grey bar.
Figure 7
Figure 7
Receiver operating characteristic (ROC) analysis: (a) ROC curves of the VCBS scale in COVID-19 vaccine acceptance screening; (b) ROC curves for 5C subscales in COVID-19 vaccine acceptance screening.
Figure 8
Figure 8
The correlation between vaccine conspiracy belief scale and the main source of knowledge about COVID-19 vaccines. p value was calculated using ANOVA test. CI: confidence interval of the mean.

Similar articles

Cited by

References

    1. The World Health Organization (WHO) Ten Threats to Global Health in 2019. [(accessed on 12 April 2021)]; Available online: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-....
    1. Wiysonge C.S., Ndwandwe D., Ryan J., Jaca A., Batoure O., Anya B.M., Cooper S. Vaccine hesitancy in the era of COVID-19: Could lessons from the past help in divining the future? Hum. Vaccines Immunother. 2021:1–3. doi: 10.1080/21645515.2021.1893062. - DOI - PMC - PubMed
    1. Dror A.A., Eisenbach N., Taiber S., Morozov N.G., Mizrachi M., Zigron A., Srouji S., Sela E. Vaccine hesitancy: The next challenge in the fight against COVID-19. Eur. J. Epidemiol. 2020;35:775–779. doi: 10.1007/s10654-020-00671-y. - DOI - PMC - PubMed
    1. Lin C., Tu P., Beitsch L.M. Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review. Vaccines. 2020;9 doi: 10.3390/vaccines9010016. - DOI - PMC - PubMed
    1. Wouters O.J., Shadlen K.C., Salcher-Konrad M., Pollard A.J., Larson H.J., Teerawattananon Y., Jit M. Challenges in ensuring global access to COVID-19 vaccines: Production, affordability, allocation, and deployment. Lancet. 2021;397:1023–1034. doi: 10.1016/S0140-6736(21)00306-8. - DOI - PMC - PubMed

LinkOut - more resources